Self-start HIV Post exposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy

Julie Fox, Ming. J Lee, Cassie Fairhead, Lesedi Ledwaba-Chapman, Achyuta Nori, Orla McQuillan, Yanzhong Wang, Amanda Clarke, Anatole Menon-Johansson

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
40 Downloads (Pure)

Abstract

Background
Effectiveness of HIV postexposure prophylaxis (PEPSE) correlates with speed of uptake following HIV exposure. Time to first dose has not improved in the UK for over 10 years. On-demand pre-exposure prophylaxis (PrEP) has shown that people can self-start medication for HIV prevention. We hypothesised that advanced provision of PEPSE (HOME PEPSE) for men who have sex with men (MSM) to self- initiate would reduce time to first dose following HIV exposure.


Methods
Phase IV, randomised, prospective, 48-week, open-label study was carried out. MSM at medium risk of acquiring HIV were randomised (1:1) to immediate or deferred standard of care (SOC) HOME PEPSE. Every 12 weeks, participants self-completed mental health/risk behaviour surveys and had HIV/sexually transmitted infection (STI) testing. HOME PEPSE comprised a 5-day pack of emtricitabine/tenofovir disoproxil fumarate/maraviroc 600 mg once daily initiated following potential exposure to HIV. If taken, participants completed a risk survey; PEPSE continuation was physician directed. Primary outcome was time from potential exposure to HIV to first PEPSE dose.


Findings
139 participants randomised 1:1; 69 to immediate HOME PEPSE and 70 to deferred HOME PEPSE. Median age 30 years (IQR 26–39), 75% white, 55% UK born and 72% university educated. 31 in HOME PEPSE and 15 in SOC arm initiated PEPSE. Uptake of HOME PEPSE was appropriate in 27/31 cases (87%, 95% CI: 71% to 95%). Median time from exposure to first dose was 7.3 hours (3.0, 20.9) for HOME PEPSE and 28.5 hours (17.3, 34.0) for SOC (p

Interpretation
HOME PEPSE reduced the time from exposure to first-dose PEPSE by 21+ hours, with no impact on safety. This significantly improves the efficacy of PEPSE and provides an option for people declining PrEP.
Original languageEnglish
JournalSEXUALLY TRANSMITTED INFECTIONS
Early online date23 Dec 2022
DOIs
Publication statusE-pub ahead of print - 23 Dec 2022

Fingerprint

Dive into the research topics of 'Self-start HIV Post exposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy'. Together they form a unique fingerprint.

Cite this